Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Bioceres Crop Solutions (BIOX) Retained Earnings (2021 - 2022)

Bioceres Crop Solutions' Retained Earnings history spans 2 years, with the latest figure at -$373.5 million for Q2 2022.

On a quarterly basis, Retained Earnings changed N/A to -$373.5 million in Q2 2022 year-over-year; TTM through Jun 2022 was -$373.5 million, a N/A change, with the full-year FY2022 number at -$373.5 million, changed N/A from a year prior.
Retained Earnings hit -$373.5 million in Q2 2022 for Bioceres Crop Solutions, down from -$357.4 million in the prior quarter.
Over the last five years, Retained Earnings for BIOX hit a ceiling of -$357.4 million in Q4 2021 and a floor of -$373.5 million in Q2 2022.